Skip to main content

Table 1 Effects of ASI on FS (%)

From: Effects of Astragaloside IV on heart failure in rats

Group

Dose (mg/kg/day)

Normal

Before treatment

After treatment

1 week

2 weeks

Sham

-

73.0 ± 5.7

68.8 ± 6.5

70.9 ± 3.4

66.1 ± 8.0

Model

-

68.8 ± 10.1 (0.2193)

30.8 ± 5.0+++

26.1 ± 6.6+++

22.7 ± 7.6+++

ASI

0.1

72.8 ± 3.6 (0.2417)

28.9 ± 4.6 (0.4213)

34.2 ± 7.5* (0.0163)

27.4 ± 7.8 (0.2620)

ASI

0.3

72.1 ± 9.6 (0.3329)

28.8 ± 6.9 (0.3973)

41.5 ± 11.3***

28.8 ± 8.9 (0.1474)

ASI

1.0

68.4 ± 6.7 (0.9061)

31.7 ± 2.5 (0.7024)

42.9 ± 7.7***

35.8 ± 13.2** (0.0028)

Quinapril

1.0

70.1 ± 7.5 (0.7016)

30.2 ± 4.7 (0.7989)

42.4 ± 4.7***

31.4 ± 8.8* (0.0411)

  1. Note: Values are mean ± SD in each group (n = 10). +++P < 0.001: statistical significance over the sham group (comparison of group means after ANOVA). *P < 0.05, **P < 0.01, ***P < 0.001: statistical significances over the model group (comparison of group means after ANOVA). No statistical significance between ASI (1.0 mg/kg/day) and Quinapril treatments. Exact P values are available in brackets.